AHCC® Supplementation May Support the Immune System to Eradicate the Human Papilloma Virus (HPV)
Preliminary results from one of the presentations made at the recent Society for Integrative Oncology 15th international conference in Scottsdale, Arizona, showed that that daily supplementation with AHCC® could support the host immune system to eradicate human papillomavirus (HPV) infection in women with HPV-positive PAP smears. Early results of the ongoing clinical trial evaluating AHCC® for treatment of HPV were presented by principle investigator Dr. Judith A. Smith of McGovern Medical at the University of Texas Health Science Center at Houston (UTHealth).









0 Comments